Sy
Synlogic
Cambridge MAFounded 201480 employees
Private CapbiotechAcquiredRare DiseaseMetabolic
Platform: Synth Bio Microbe
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SYN-451 | SYN-451 | NDA/BLA | 2 | SGLT2 | ACCMDD | ||
| Fixatenlimab | SYN-8667 | NDA/BLA | 2 | MALT1 | Prostate CaMeso |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)